Patents by Inventor Bradford Hamilton

Bradford Hamilton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
    Publication number: 20080103138
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: December 19, 2007
    Publication date: May 1, 2008
    Inventors: Thomas Trieselmann, Rainer Walter, Matthew Netherton, Marco Santagostino, Bradford Hamilton
  • Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
    Publication number: 20070112033
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in ths claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: October 19, 2006
    Publication date: May 17, 2007
    Inventors: Thomas Trieselmann, Rainer Walter, Matthew Netherton, Marco Santagostino, Bradford Hamilton
  • Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
    Publication number: 20070105906
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: October 19, 2006
    Publication date: May 10, 2007
    Inventors: Rainer Walter, Bradford Hamilton, Thomas Trieselmann, Matthew Netherton, Marco Santagostino, Ingo Konetzki
  • New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
    Publication number: 20060173061
    Abstract: The present invention relates to new beta-agonists of general formula 1: wherein the groups R1 to R12 have the meanings given in the claims and specification, the isomers thereof, processes for preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: March 9, 2006
    Publication date: August 3, 2006
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Thomas Trieselmann, Bradford Hamilton, Dirk Stenkamp, Stephan Mueller
  • Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
    Publication number: 20050245526
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R7 have the meanings given in the claims and specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, processes for preparing these compounds and their use as pharmaceutical compositions.
    Type: Application
    Filed: April 29, 2005
    Publication date: November 3, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Thomas Trieselmann, Bradford Hamilton